CB
Insider
Camille L Bedrosian
Chief Medical OfficerCamille L Bedrosian (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Amylyx Pharmaceuticals, Inc. (AMLX). The largest single filing was $256K of AMLX (7,947 sh × $32.21, as filed), executed Sep 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$432K
shares × price, as filed
Last traded
Sep 10
Filed Sep 14
Median ADV $78.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $432K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
AMLXRecent filings
AMLXSALE
Amylyx Pharmaceuticals, Inc.
View filing →
$256K7,947 sh × $32.21
Exec Sep 10
Filed Sep 14 · 4:00 PM ET AMLXSALE Amylyx Pharmaceuticals, Inc. View filing → $176K
12,039 sh × $14.58
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET